Table 2.

Detailed clinical characteristics of patients with BPD.

Patients	Medication	Current comorbidity	History of comorbidity
1	Quetiapine 50 mg, Fluoxetine 20 mg	PTSD	Substance abuse
2	Olanzapine 5 mg, Quetiapine 600 mg (prolong), Escitalopram 20 mg	Alcohol abuse	MDD
3	Escitalopram 20 mg, Zopiclone 7.5 mg	Bulimia nervosa	Recurrent MDD
4	Quetiapine 100 mg, Lamotrigine 12.5 mg	Substance abuse, Cannabis dependence	Recurrent MDD
5	Quetiapine 300 mg (prolong), Sertraline 150 mg, Aripiprazole 10 mg	Multiple personality disorders	None
6	None	None	None
7	Atomoxetine 50 mg, Fluoxetine 20 mg, Paliperidone 3 mg	MDD, ADHD, alcohol abuse	Anorexia nervosa, recurrent MDD
8	Fluoxetine 40 mg	MDD	Substance abuse
9	Fluoxetine 30 mg, Quetiapine 12.5 mg, Pregabalin 225 mg	Undifferentiated somatoform disorder, alcohol abuse	Alcohol abuse
10	Aripiprazole 20 mg, Venlafaxine 150 mg	Alcohol abuse	Alcohol abuse
11	Pregabalin 300 mg, Quetiapine 60 mg, Venlafaxine 225 mg	PTSD, undifferentiated somatoform disorder, alcohol dependence	Recurrent MDD
12	None	None	None
13	Sertraline 75 mg	PTSD, substance abuse	Recurrent MDD
14	Sertraline 50 mg	Cannabis abuse	Recurrent MDD

BPD, borderline personality disorder; PTSD, post-traumatic stress disorder; MDD, major depressive disorder.